Featured Research

from universities, journals, and other organizations

Cancer drugs hitch a ride on 'smart' gold nanoshells

Date:
February 13, 2014
Source:
Institute of Physics
Summary:
Nanoparticles capable of delivering drugs to specifically targeted cancer cells have been created by a group of researchers from China.

Nanoparticles capable of delivering drugs to specifically targeted cancer cells have been created by a group of researchers from China.

The multifunctional 'smart' gold nanoshells could lead to more effective cancer treatments by overcoming a major limitation of modern chemotherapy techniques -- the ability to target cancer cells specifically and leave healthy cells untouched.

Small peptides situated on the surface of the nanoshells are the key to the improved targeting ability, guiding the nanoshells to specific cancer cells and attaching to markers on the surface of the cells. The acidic environment of the cancer cells then triggers the offloading of the anticancer drugs.

The specific nanostructure of the gold nanoshells could also allow near-infrared light to be absorbed and converted into heat, opening up the possibility of using the nanoshells in targeted hyperthermia treatment -- another form of cancer treatment whereby cancer cells are exposed to slightly higher temperatures than usual to destroy them.

The first results of the nanoshells' performance have been published 14 February, in IOP Publishing's journal Biomedical Materials.

The researchers, from East China Normal University and Tongji University, used the gold nanoshells as a building block to which they attached the commonly used anticancer drug Doxorubicin (DOX) and a specific peptide known as A54.

The gold nanoshells had diameters of around 200 nanometres -- more than 50 times smaller than a red blood cell.

When tested on human liver cancer cells, the uptake of the nanoshells that had the A45 peptide was three times greater than the uptake of the control nanoshells without the peptide. There was also a significantly reduced uptake of both types of nanoshell by normal healthy cells.

The cancer cells were also treated with the gold nanoshells in a heated water bath and were shown to deliver a notable therapeutic effect compared to just the chemotherapy, demonstrating the potential of the hyperthermia treatment.

Lead author of the study Dr Shunying Liu, from East China Normal University, said: "The therapeutic activity of most anticancer drugs is limited by their systematic toxicity to proliferating cells, including some normal cells. Overcoming this problem remains a great challenge for chemotherapy."

"In our study we placed a targeting peptide on the nanoshells, which have been demonstrated to be specific to live cancer cells, improving the targeting ability and drug delivery of the gold nanoshells.

"The next step of our research is to test the 'smart' gold nanoshells in vivo on a liver cancer mouse model. We will also examine how the size of the nanoshells changes their efficacy and how efficient the nanoshells are at converting near-infrared light into heat."


Story Source:

The above story is based on materials provided by Institute of Physics. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zhongshi Liang, Xingui Li, Yegui Xie, Shunying Liu. ‘Smart’ gold nanoshells for combined cancer chemotherapy and hyperthermia. Biomedical Materials, 2014; 9 (2): 025012 DOI: 10.1088/1748-6041/9/2/025012

Cite This Page:

Institute of Physics. "Cancer drugs hitch a ride on 'smart' gold nanoshells." ScienceDaily. ScienceDaily, 13 February 2014. <www.sciencedaily.com/releases/2014/02/140213220423.htm>.
Institute of Physics. (2014, February 13). Cancer drugs hitch a ride on 'smart' gold nanoshells. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2014/02/140213220423.htm
Institute of Physics. "Cancer drugs hitch a ride on 'smart' gold nanoshells." ScienceDaily. www.sciencedaily.com/releases/2014/02/140213220423.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins